Virios Therapeutics (VIRI) Scheduled to Post Earnings on Thursday

Virios Therapeutics (NASDAQ:VIRI) will issue its quarterly earnings data before the market opens on Thursday, May 9th. Analysts expect the company to announce earnings of ($0.08) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

Virios Therapeutics (NASDAQ:VIRI) last announced its quarterly earnings results on Thursday, February 29th. The company reported ($0.06) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.03. On average, analysts expect Virios Therapeutics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Virios Therapeutics Stock Performance

Shares of NASDAQ VIRI opened at $0.41 on Wednesday. Virios Therapeutics has a 52-week low of $0.28 and a 52-week high of $2.42. The stock has a market cap of $7.95 million, a P/E ratio of -1.48 and a beta of 1.87. The firm has a 50 day moving average price of $0.42 and a 200 day moving average price of $0.52.

About Virios Therapeutics

Virios Therapeutics, Inc, a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia.